Management of Dengue Fever Dr David Tran 16/09/09.

Slides:



Advertisements
Similar presentations
DENGUE HEMORRHAGIC FEVER
Advertisements

Flight Surgeon RSV Day I n t e g r i t y - S e r v i c e - E x c e l l e n c e ANGRC Joint Base Andrews UNCLASSIFIED.
Epidemic hemorrhagic fever ----hemorrhagic fever with renal syndrome , HFRS.
Development Committee
Juan Flores Jasmine Ibarra
2 Module 1 Pathophysiology Clinical course WHO classification & limitation Other manifestations Dr Suresh Kumar Infectious Diseases Unit Hospital Sungai.
III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.
Blood Products Advisory Committee Meeting Harold S. Gaithersburg, MD December 14, 2010 Harold S. Margolis, MD Chief, Dengue Branch Centers for Disease.
Dengue Divya Bappanad Karapitya Hospital Galle, Sri Lanka.
Arthropod-borne Viruses Arthropod-borne viruses (arboviruses) are viruses that can be transmitted to man by arthropod vectors. Arboviruses belong to three.
DENGUE AND ITS MANAGEMENT
Tessa Bandhan. Question 1 A 3 year old girl known to have sickle cell disease (Hb SS) presents to the Emergency Room with a 2 day history of weakness.
Dengue Virus Causes dengue and dengue hemorrhagic fever
The Febrile Returned Traveler and Dengue Fever AM Report Sept. 25, 2009.
Case Study: Dengue Virus Virology 516 Fall 2007 Milette Mahinan, Suzi Sanchez, Olayinka Taiwo.
Ebola Facts October 14, Symptoms of Ebola Initial symptoms are nonspecific - may include fever, chills, myalgias, and malaise. Patients can progress.
FECAL-BORNE HEPATITIS. ETIOLOGY Hepatitis A virus (HAV), Hepatovirus Picornavirus, enterovirus nm 1 serotype only, although there are 4 genotypes.
Management of Severe Dengue
DR.MOHAMMED ARIF ASSOCIATE PROFESSOR CONSULTANT VIROLOGIST HEAD OF THE VIROLOGY UNIT Cytomegalovirus (CMV)
Dr. Paramita Sengupta Department Of Community Medicine Christian Medical College Ludhiana Co-authors: Ragini Mann, Rohit Theodore, A I Benjamin Risk factors.
Dengue fever Febrile phase 2-7 DAYS Convalescent phase 2-5 DAYS Longer in adults 1.
DENGUE & DENGUE HEMORRHAGIC FEVER Rab Chaudhry + Arzaan Shaikh.
Dengue Fever Brian Rochana Aurora Cardenas David Marquez.
Andrea Montelibano Isabelle Escobillo. The Virus Flavivirus Single strand RNA 4 serotypes – DENV-1 – DENV-2 – DENV-3 – DENV-4 Infection with one serotype.
W HAT ` S N EW IN DHF: C LINICAL ASPECT Professor Siripen Kalayanarooj, Director, WHO Collaborating Centre for Case Management of Dengue/DHF/DSS, Queen.
Case 7: “Pesteng Lamok”. “PESTENG LAMOK”  A 7 year old male child has been having fever (maximum 39 0 C) for the past 4 days.This was associated with.
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 3 ID HSB 2015.
Morning Report August 4, 2009.
OSCE Question 02/2015 TMH AED.
Clinical Presentation of DHF. Dengue should be considered in the differential diagnosis of febrile patients with a history of travel to the tropics in.
Dengue ..
D NGUE WORKSHOP 2015 E ID HSB 2015.
PROF. DR. MUHAMMAD YAQUB KAZI MBBS, MCPS (Family Medicine) DCH (Pb), MCPS (Paeds), FCPS (Paeds), FRCP (Edin), FRCP (London), FRCPCH (UK) Ex Dean, Institute.
DR. MOHAMMED ARIF. ASSOCIATE PROFESSOR AND CONSULTANT VIROLOGIST. Non-arboviruses associated with zoonotic diseases.
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
VII. Treatment. Outpatient Triage n No hemorrhagic manifestations and patient is well-hydrated: home treatment n Hemorrhagic manifestations or hydration.
Acute Viral Hepatitis Dr.Akhavan.
Tropical Fevers Case 1: 27 year old woman comes to a local health unit with history of a gradual onset of fever and headache and loss of appetite over.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES.
Crimean-Congo hemorrhagic fever virus Syeda Zainab Ali Bukhari
Classic Presentation of Inhalational Anthrax Initial phase -Malaise, fatigue, fever, myalgias, non-productive cough -1-4 days Fulminant phase -Respiratory.
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
DENGUE INFECTION 1ST ENCOUNTER CPG Mx of Dengue Infection Revised 2 nd Edition, 2010 Mohd Ghazali AR, 21th November 2012.
Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement.
DR.S. MANSORI INFECTIOUS DISEASE SPECIALIST QAZVIN UNIVERCITY OF MEDICAL SCIENCE.
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) ,
VIRAL HAEMORRHAGIC FEVERS BY DR UCHE UNIGWE. Lassa fever Yellow fever Marburg/Ebola HF Dengue HF Crimean- Congo HF Hanta virus HF.
DENGUE FEVER Prof. Dr. Muhammad Ali Khan MBBS, DCH, MRCP (UK)
Internal Medicine Workshop Series Laos September /October 2009
Ebola Facts October 14, 2014.
Dr.Humra nasim PGT-Medicine HFH,RWP
Epidemiology Clinical features Epidemiological Investigation
Most cases occur in older children and adults
The virus that does not cause chronic liver disease
VIRAL HAEMORRHAGIC FEVERS
CLINICAL PROFILE OF DENGUE FEVER
From: Clinical and Laboratory Diagnosis of Dengue Virus Infection
PRESENTATION BY: IBRAHIM KAULA IBRAHIM JR
Ebola Facts October 14, 2014.
Dengue Virus Infections Investigation Guideline
Dr. Keerti Singh Assistant Professor SGRRITS
Ebola Facts October 14, 2014.
ASPEK VIRUS RUBELLA.
Ebola Facts October 14, 2014.
Ebola Facts October 14, 2014.
Challenges, Consideration, and Progress
Presentation transcript:

Management of Dengue Fever Dr David Tran 16/09/09

Classic clinical dengue fever Incubation period 3 to 14 days (usually 4 to 7 days) Sudden onset of fever with severe headache Retro-orbital pain, fatigue Often associated with myalgia and arthralgia Duration of fever usually 5 to 7 days Sometime maculopapular rash (50% to 66% of cases) Other non specific signs as inflamed pharynx, gastro-intestinal symptoms

Classic definition of dengue fever (WHO 1997)

Hemorrhagic manifestations / biologic abnormalities Petechiae, purpura Gum bleeding, epistaxis, menorrhagia, gastro- intestinal bleedings (rare) Thrombocytopenia, leukopenia with lymphopenia Mild elevation of hepatic transaminases & LDH

Definition of dengue hemorrhagic fever (WHO 1997)

Dengue hemorrhagic fever & Dengue shock syndrome Physiopathology: capillary leakage & hemorrhagic manifestations. 4 to 7 days after the onset (at approximately the date of defervescence) Abdominal pain, vomiting, consciousness troubles, hypothermia Marked decrease in platelet count. Mortality: up to 10 or 20%

Definition of dengue shock syndrome (WHO 1997)

Diagnosis of dengue hemorrhagic fever (triad of symptoms) Hemorrhagic manifestations Platelet count 3 rd day of illness) Evidence of plasma leakage (Hematocrite  pleural effusion, ascites, hypoproteinemia)

Lowest platelet count by day of illness in adult dengue hemorrhagic patients

Dengue shock syndrome Rapid weak pulse & low blood pressure (BP < 90mmHg) The duration of this shock is short after appropriate volume replacement therapy (Colloid or Cristalloid infusions) Mortality rate is up to 40%

Different clinical presentation of dengue fever

Serodiagnosis of dengue fever Serology (IgM capture ELISA) Problem: negativity of the test early in the course of the disease > should be performed only 4 to 5 days after the onset of fever. IgM: remain positive for 3 to 6 month IgG: remain positive for life

Dengue NS1 antigen testing Early detection of Ag NS1 in blood sample of infected patients > confirm early acute infection Detection of all 4 types of dengue serotypes Result available in 15 min. (BioRad ® chromatographic strip test) High specificity (100%) and positive predictive value

Although in some reports, the same efficiency of detection for virus of the 4 serotypes has been described for the Dengue Early ELISA and Strip tests (Dussart et al., 2008), A recent analysis of the performance of these tests in Vietnam suggests a lower sensitivity for DENV-2 compared with DENV-1 and DENV-3.

Problem of sensibility of NS1 detection tests (Ramirez, diagnostic microbiology & infectious disease, Sept 2009) These tests in Vietnam suggests a lower sensitivity for DENV-2 compared with DENV-1 and DENV-3. Also, a decreased sensitivity for DENV-4 with the Dengue Early ELISA has been reported in studies from South America (Bessoff et al., 2008; Dussart et al., 2008). A lower sensitivity for DENV-2 has been described in samples from Vietnam (Hang et al., 2009) tested by the PLATELIA ™ systems (ELISA and Strip) and belonging to the Asian genotype 1 (according to the classification of Twiddy et al., 2002).

Sensitivity of NS1 Ag detection tests according to the day of illness (Mc Bride, Diagnostic Microbiology & Infectious Diseases, 64 – 2009 – 31,36)

Management of dengue virus infected patient Most of cases can be managed on an outpatient basis (antipyretic like paracetamol, bed rest, oral hydratation) Platelet counts and hematocrite determination should be repeated at least every 24 hours Patient with platelet count < should be hospitalized (high risk for dengue hemorrhagic & dengue shock syndrome)